norfenfluramine has been researched along with paroxetine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnson, MP; Nichols, DE | 1 |
| Rowland, NE | 1 |
| Cozzi, NV; Frescas, S; Huang, X; Marona-Lewicka, D; Nichols, DE | 1 |
3 other study(ies) available for norfenfluramine and paroxetine
| Article | Year |
|---|---|
Comparative serotonin neurotoxicity of the stereoisomers of fenfluramine and norfenfluramine.
Topics: Animals; Biogenic Monoamines; Fenfluramine; Frontal Lobe; Hippocampus; Male; Neurons; Norfenfluramine; Paroxetine; Piperidines; Rats; Rats, Inbred Strains; Serotonin; Stereoisomerism | 1990 |
Long-term administration of dexfenfluramine to genetically obese (ob/ob) and lean mice: body weight and brain serotonin changes.
Topics: Animals; Blood Glucose; Body Weight; Brain Chemistry; Corticosterone; Dietary Fats; Female; Fenfluramine; Mice; Mice, Inbred C57BL; Mice, Obese; Norfenfluramine; Obesity; Paroxetine; Serotonin | 1994 |
Indan analogs of fenfluramine and norfenfluramine have reduced neurotoxic potential.
Topics: Animals; Appetite Depressants; Body Weight; Brain Chemistry; Discrimination, Psychological; Fenfluramine; In Vitro Techniques; Indans; Male; Nervous System Diseases; Neurotransmitter Uptake Inhibitors; Norfenfluramine; Paroxetine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Serotonin; Synaptosomes | 1998 |